Literature DB >> 8593889

Differential trophic effects of basic fibroblast growth factor, insulin-like growth factor-1, and neurotrophin-3 on striatal neurons in culture.

N Nakao1, P Odin, O Lindvall, P Brundin.   

Abstract

We have examined the trophic effects of basic fibroblast growth factor (bFGF), truncated insulin-like growth factor-1 (tIGF), and neurotrophin-3 (NT-3) on embryonic striatal neurons grown under serum-free culture conditions. Striatal neurons were identified using immunocytochemistry for dopamine- and cyclic AMP-regulated phosphoprotein (DARPP-32). In our serum-free striatal cultures, the survival and the development of DARPP-32- containing neurons were dependent on initial plating density: relatively high density cultures yielded disproportionately increased number of harvested DARPP-32- positive neurons. All three growth factors, bFGF (10 ng/ml), tIGF-1 (50 ng/ml), and NT-3 (50 ng/ml), promoted the survival of DARPP-32-positive neurons, with bFGF being significantly more effective than tIGF-1 and NT-3. Exposure to bFGF also significantly increased the total cell number compared to control cultures, whereas there was only a tendency toward more (20-30%) surviving cells in cultures treated with either tIGF-1 or NT-3. With the concentrations used, only bFGF gave rise to a significant increase (80%) in the number of glial fibrillary acidic protein-immunopositive glia as compared to controls. The most pronounced effect on morphological development of DARPP-32-containing neurons was seen with NT-3, which increased the length of neurites, the number of branching points on the neurites, and the soma area. There was no alteration of the morphology of this neuronal population in bFGF-treated cultures. All of these growth factors were seen to be approximately equally efficient at protecting striatal neurons from N-methyl-D- aspartate-induced excitotoxicity. These data indicate that bFGF, tIGF-1, and NT3 exert different trophic activities on striatal neurons in vitro and suggest that these growth factors might also be involved in the regulation of neuronal development and maintenance in the striatum.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8593889     DOI: 10.1006/exnr.1996.0053

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  9 in total

Review 1.  Cell therapy in Huntington's disease.

Authors:  Stephen B Dunnett; Anne E Rosser
Journal:  NeuroRx       Date:  2004-10

Review 2.  Insulin-like growth factor-I is a differentiation factor for postmitotic CNS stem cell-derived neuronal precursors: distinct actions from those of brain-derived neurotrophic factor.

Authors:  Y Arsenijevic; S Weiss
Journal:  J Neurosci       Date:  1998-03-15       Impact factor: 6.167

3.  Brain derived neurotrophic factor protects human neuroblastoma cells from DNA damaging agents.

Authors:  D S Middlemas; B K Kihl; N M Moody
Journal:  J Neurooncol       Date:  1999       Impact factor: 4.130

Review 4.  Neuroprotective strategies for HIV-1 associated dementia.

Authors:  Huanyu Dou; Jeffrey D Kingsley; R Lee Mosley; Harris A Gelbard; Howard E Gendelman
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

5.  Expression of the striatal DARPP-32/ARPP-21 phenotype in GABAergic neurons requires neurotrophins in vivo and in vitro.

Authors:  S Ivkovic; M E Ehrlich
Journal:  J Neurosci       Date:  1999-07-01       Impact factor: 6.167

6.  IGF-1 and bFGF reduce glutaric acid and 3-hydroxyglutaric acid toxicity in striatal cultures.

Authors:  K B Bjugstad; W M Zawada; S Goodman; C R Freed
Journal:  J Inherit Metab Dis       Date:  2001-11       Impact factor: 4.982

7.  Neurotrophic growth factors for the treatment of amyotrophic lateral sclerosis: where do we stand?

Authors:  Alexandre Henriques; Claudia Pitzer; Armin Schneider
Journal:  Front Neurosci       Date:  2010-06-11       Impact factor: 4.677

Review 8.  Molecular pathogenesis and cellular pathology of spinocerebellar ataxia type 7 neurodegeneration.

Authors:  Gwenn A Garden; Albert R La Spada
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

9.  IGF-1 and pAKT signaling promote hippocampal CA1 neuronal survival following injury to dentate granule cells.

Authors:  Robert N Wine; Christopher A McPherson; G Jean Harry
Journal:  Neurotox Res       Date:  2009-05-28       Impact factor: 3.911

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.